Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1763, Issue 8, 2006, Pages 879-888

  Amon, Michael A ^a   Ali, Marina ^a   Bender, Vera ^a   Chan, Yiu Ngok ^b   Toth, Istvan ^c   Manolios, Nicholas ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Lipopeptides; Peptide conjugation; Peptides; T cell antigen receptor; Transmembranes

Indexed keywords

1 AMINOGLUCOSE SUCCINATE; AMINO ACID DERIVATIVE; DIPALMITATE; GLYCYLLEUCYLARGINYLISOLEUCYLLEUCYLLEUCYLLEUCYLLYSYLVALINE; INTERLEUKIN 2; LIPID; LIPOAMINO ACID; MYRISTIC ACID; PALMITIC ACID; PALMITIC ACID DERIVATIVE; PEPTIDE DERIVATIVE; SUCCINIC ACID DERIVATIVE; SUGAR; T LYMPHOCYTE RECEPTOR; TRIPALMITATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; GLYCOSYLATION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD3; ARTHRITIS, EXPERIMENTAL; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CROSS-LINKING REAGENTS; ENTEROTOXINS; FEMALE; GLYCOSYLATION; HYDROPHOBICITY; INTERLEUKIN-2; IONOMYCIN; LIPIDS; LYMPHOCYTE ACTIVATION; MICE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 33747036119     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.04.013     Document Type: Article

References (54)

1. Bates S.M., Lister-James J., Julian J.A., Taillefer R., Moyer B.R., and Ginsberg J.S. Imaging characteristics of a novel Technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients with acute deep vein thrombosis or a history of deep vein thrombosis. Arch. Intern. Med. 163 (2003) 452-456
2. Albertario S., Forti P., Bianchi C., Morone G., Tinozzi F., Moglia P., Abelli M., Benedetti M., and Aprile C. Radioguided surgery for gastrinoma: a case report. Tumori 88 (2002) S41-S43
3. Cervia J.S., and Smith M.A. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor. Clin. Infect. Dis. 37 (2003) 1102-1106
4. McClesky E.W., Fox A.P., Feldman D.H., Cruz L.J., Olivera B.M., Tsien R.W., and Yoshikami D. ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 4327-4331
5. Proksch P., Edrada R., and Ebel P. Drugs from the seas - current status and microbiological implications. Appl. Microbiol. Biotechnol. 59 (2002) 125-134
6. Dhib-Jalbut S. Glatiramer acetate (Copaxone1) therapy for multiple sclerosis. Pharmacol. Ther. 98 (2003) 129-265
7. Borghardt J., Rosien B., Gortelmeyer R., Lindemann S., Hartleb M., and Klingmuller M. Effects of a spleen peptide preparation as supportive therapy in inoperable head and neck cancer patients. Arzneim.-Forsch. 50 (2000) 178-184
8. Shield C.F.I., McGrath M.M., and Goss T.F. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. Transplantation 64 (1997) 1738-1743
9. Mutchnick M.G., Lindsay K.L., Schiff E.R., Cummings G.D., Appelman H.D., Peleman R.R., Silva M., Roach K.C., Simmons F., Milstein S., Gordon S.C., and Ehrinpreis M.N. Thymosin [alpha]1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study. J. Viral Hepatitis 6 (1999) 397-403
10. Sehgal A. Recent developments in peptide-based cancer therapeutics. Curr. Opin. Drug Discov. Dev. 5 (2002) 245-250
11. Wang H.-L., and Kurtz A. Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108 Space. Oncogene 19 (2000) 2455-2460
12. Latham P.W. Therapeutic peptides revisited. Nat. Biotechnol. 17 (1999) 755-757
13. Ali M., and Manolios N. Peptide delivery systems. Lett. Pept. Sci. 8 (2002) 289-294
14. Burton P.S., Conradi R.A., Ho N.F.H., Hilgers A.R., and Borchardt R.T. How structural features influence the biomembrane permeability of peptides. J. Pharm. Sci. 85 (1996) 1336-1340
15. Drouillat B., Hillery A.M., Dekany G., Falconer R., Wright K., and Toth I. Novel liposaccharide conjugates for drug and peptide delivery. J. Pharm. Sci. 87 (1998) 25-30
16. Schelhaas M., Nagele E., Kuder N., Bader B., Kuhlmann J., Wirringhofer A., and Waldmann H. Chemoenzymatic synthesis of biotinylated ras peptides and their use in membrane binding studies of lipidated model proteins by surface plasmon resonance. Chem. Eur. J. 5 (1999) 1239-1252
17. Peters C., Wagner M., Volkert M., and Waldmann H. Bridging the gap between cell biology and organic chemistry: chemical synthesis and biological application of lipidated peptides and proteins. Naturwissenschaften 89 (2002) 381-390
18. Mora A.L., and Tam J.P. Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations. The J. Immunol. 161 (1998) 3616-3623
19. Wang J., Shen D., and Shen W.-C. Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity. Pharm. Res. 16 (1999) 1674-1679
20. Whittaker R.G., Hayes P.J., and Bender V.J. A gentle method for linking Tris to amino acids and peptides. Pept. Res. 6 (1993) 125-128
21. Toth I. A novel chemical approach to drug delivery: lipidic amino acid conjugates. J. Drug Target. 2 (1994) 217-239
22. Otvos L.J., Wade J.D., Lin F., Condie B.A., Hanrieder J., and Hoffmann R. Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J. Med. Chem. 48 (2005) 5349-5359
23. von Itzstein M., Wu W.-Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Phan T.V., Smythe M.L., White H.F., Oliver S.W., Colman P.M., Varghese J.N., Ryan D.M., Woods J.M., Bethell R.C., Hotham V.J., Cameron J.M., and Penn C.R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 (1993) 418-423
24. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., and Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T-cell mediated disease. Nat. Med. 3 (1997) 84-88
25. Manolios N. Structure and assembly of the TCR. Today's Life Sci. 4 (1992) 32-43
26. Call M.E., Pyrdol J., Wiedmann M., and Wucherpfennig K.W. The organizing principle in the formation of the T Cell receptor-CD3 complex. Cell 111 (2002) 967-979
27. Wang X.M., Djordjevic J.T., Bender V., and Manolios N. T cell antigen receptor (TCR) transmembrane peptides colocalize with TCR, not lipid rafts, in surface membranes. Cell. Immunol. 215 (2002) 12-19
28. Wang X.M., Djordjevic J.T., Kurosaka N., Schibeci S., Lee L., Williamson P., and Manolios N. T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer. Clin. Immunol. 105 (2002) 199-207
29. Bender V., Ali M., Amon M., Diefenbach E., and Manolios N. T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance. The J. Biol. Chem. 279 (2004) 54002-54007
30. Gollner G., Muller G., Alt R., Knop J., and Enk A.H. Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell mediated skin diseases. Gene Ther. 7 (2000) 1000-1004
31. Mahnke K., Yingjie Q., Knop J., and Enk A.H. Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo. Nat. Biotechnol. 21 (2003) 903-908
32. Leo O., Foo M., Sachs D.H., Samelson L.E., and Bluestone J.A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 1374-1378
33. Kubo R.T., Born W., Kappler J.W., Marrack P., and Pigeon M. Characterization of a monoclonal antibody which detects all murine ab T cell receptors. The J. Immunol. 142 (1989) 2736-2742
34. Wang J.-h., Lim K., Smolyar A., Teng M.-k., Liu J.-h., Tse A.G.D., Liu J., Hussey R.E., Chishti Y., Thomson C.T., Sweet R.M., Nathanson S.G., Chang H.-C., Sacchettini J.C., and Reinherz E.L. Atomic structure of an ab T cell receptor (TCR) heterodimer in complex with an anti-TCR Fab fragment derived from a mitogenic antibody. The EMBO J. 17 (1998) 10-26
35. Gibbons W.A., Hughes R.A., Chralambous M., Szeto A., Aulabaugh A.E., Maseagni P., and Toth I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers. Liebigs Ann. Chem. (1990) 1175-1183
36. Ross B.P., DeCruz S.E., Lynch T.B., Davis-Goff K., and Toth I. Design, synthesis and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. J. Med. Chem. 47 (2004) 1251-1258
37. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., and Bender V. Immunomodulatory antigen receptor transmembrane peptides and their effect on T-cell mediated disease. Nat. Med. 3 (1997) 84-88
38. Baker M.D., and Acharya K.R. Superantigens: structure-function relationships. Int. J. Med. Microbiol. 293 (2004) 529-537
39. Cuff L., Ulrich R.G., and Olson M.A. Prediction of the multimeric assembly of staphylococcal enterotoxin A with cell-surface protein receptors. The J. Graphics Model. 21 (2003) 473-486
40. Ghendler Y., Smolyar A., Chang H.-C., and Reinherz E.L. One of the CD3e subunits within a T cell receptor complex lies in close proximity to the Cb FG loop. J. Exp. Med. 187 (1998) 1529-1536
41. Ali M., Amon M., Bender V., and Manolios N. Hydrophobic transmembrane-peptide lipid conjugations enhance membrane binding and functional activity in T-cells. Bioconjug. Chem. 16 (2005) 1556-1563
42. Taniguchi H. Protein myristoylation in protein-lipid and protein-protein interactions. Biophys. Chemist. 82 (1999) 129-137
43. Bijlmakers M.-J., and Marsh M. The on-off story of protein palmitoylation. Trends Cell Biol. 13 (2003) 32-42
44. Lockett T., Reilly W., Manthey M., Wells X., Cameron F., Moghaddam M., Johnston J., Smith K., Francis C., Yang Q., and Whittaker R. Tris lipidation: a chemically flexible technology for modifying the delivery of drugs and genes. Clin. Exp. Pharmacol. Physiol. 27 (2000) 563-567
45. Cameron F.H., Moghaddam M.J., Bender V.J., Whittaker R.G., Mott M., and Lockett T.J. A transfection compound series based on a versatile Tris linkage. Biochim. Biophys. Acta, Biomembr. 1417 (1999) 37-50
46. Avrahami D., and Shai Y. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to d,l-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 42 (2003) 14946-14956
47. Sal-Man N., Gerber D., and Shai Y. The identification of a minimal dimerization motif QXXS that enables homo- and hetero-association of transmembrane helices in vivo. The J. Biol. Chem. 280 (2005) 27449-27457
48. Majerle A., Kidric J., and Jerala R. Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J. Antimicrob. Chemother. 51 (2003) 1159-1165
49. Toth I., Malkinson J.P., Flinn N.S., Drouillat B., Horvath A., Erchegyi J., Idei M., Venetianer A., Artursson P., Lazorova L., Szende B., and Keri G. Novel lipoamineo acid- and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analogues. J. Med. Chem. 42 (1999) 4010-4013
50. Proft T., and Fraser J. Superantigens: just like peptides only different. J. Exp. Med. 187 (1990) 819-821
51. Woodland D.L., Wen R., and Blackman M.A. Why do superantigens care about peptides?. Immunol. Today 18 (1997) 18-22
52. Sigalov A. Multi-chain immune recognition receptors: spatial organization and signal transduction. Semin. Immunol. 17 (2005) 51-64
53. Manolios N., and L.Z.G. The T cell antigen receptor beta chain interacts with the extracellular domain of CD3-gamma. Immunol. Cell Biol. 73 (1995) 532-536
54. Bender V.J., Cameron F., Hendry P., Lockett T.J., and Whittaker R.G. Delivery Studies using Peptide-Fatty Acid Conjugates (1994), ESCOM, Lieden